Loading...
 
Toggle Health Problems and D

SSRI Drugs Can Cause Chronic Fatigue Syndrome - Mercola April 2024


SSRI Drugs Can Cause Chronic Fatigue Syndrome

Mercola April 2024

STORY AT-A-GLANCE

  • SSRIs, which increase serotonin levels, have been linked to chronic fatigue syndrome (CFS). A study showed that administering Prozac (fluoxetine) to mice at high dosages induced symptoms of CFS, suggesting a link between excessive serotonin levels and the condition
  • Symptom reversal was achieved with the serotonin inhibitor fenclonine
  • Other serotonin inhibitors include Benadryl, the H2 blocker Pepcid (famotidine), aspirin, progesterone and GABA
  • Branched-chain amino acids, tyrosine, phenylalanine and L-theanine can also help reduce serotonin levels
  • GABA is a more effective solution for conditions typically treated with SSRIs, such as depression and anxiety, without the adverse effects associated with elevated serotonin
  • Reducing intake of linoleic acid (LA), found in high amounts in seed oils and certain meats, is recommended if you have CFS, as excess LA impair your mitochondrial function and cellular energy production
    • Note: LAs reduces the Omage-3

 Download the PDF from VitaminDWiki


Some SSRIs (fluoxetine) inhibit CYP27A1, thus reducing Vitamin D

Perplexity AI April 2024
The specific SSRIs that have been noted to inhibit CYP27A1 include citalopram, fluoxetine, and sertraline17. This inhibition can lead to drug-drug interactions, particularly in patients who are on multiple medications, as CYP27A1 plays a role in the metabolism of various substances1417.

VitaminDWiki - Genetics chart shows the vitamin D genes
in Visio for 2023


VitaminDWiki – Just 1500 IU of Vitamin D significantly helps Prozac – RCT March 2013


VitaminDWiki – Depression contains

Some recent publications


VitaminDWiki – Overview Fibromyalgia or Chronic Fatigue and vitamin D

SSRI Drugs Can Cause Chronic Fatigue Syndrome - Mercola April 2024        
1930 visitors, last modified 19 Apr, 2024,
(Cached) Printer Friendly Follow this page for updates